Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
This report aims to provide a comprehensive presentation of the global market for Vaccines Administered Orally, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines Administered Orally. This report contains market size and forecasts of Vaccines Administered Orally in global, including the following market information:
Global Vaccines Administered Orally Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Vaccines Administered Orally Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Vaccines Administered Orally companies in 2022 (%)
The global Vaccines Administered Orally market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Vaccines Administered Orally include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Vaccines Administered Orally manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccines Administered Orally Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Vaccines Administered Orally Market Segment Percentages, by Type, 2022 (%)
Human
Animal
Global Vaccines Administered Orally Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Vaccines Administered Orally Market Segment Percentages, by Application, 2022 (%)
Public
Private
Global Vaccines Administered Orally Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Vaccines Administered Orally Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccines Administered Orally revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Vaccines Administered Orally revenues share in global market, 2022 (%)
Key companies Vaccines Administered Orally sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Vaccines Administered Orally sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccines Administered Orally, market overview.
Chapter 2: Global Vaccines Administered Orally market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccines Administered Orally manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccines Administered Orally in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccines Administered Orally capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vaccines Administered Orally Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccines Administered Orally Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccines Administered Orally Overall Market Size
2.1 Global Vaccines Administered Orally Market Size: 2022 VS 2030
2.2 Global Vaccines Administered Orally Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Vaccines Administered Orally Sales: 2018-2030
3 Company Landscape
3.1 Top Vaccines Administered Orally Players in Global Market
3.2 Top Global Vaccines Administered Orally Companies Ranked by Revenue
3.3 Global Vaccines Administered Orally Revenue by Companies
3.4 Global Vaccines Administered Orally Sales by Companies
3.5 Global Vaccines Administered Orally Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccines Administered Orally Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccines Administered Orally Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccines Administered Orally Players in Global Market
3.8.1 List of Global Tier 1 Vaccines Administered Orally Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccines Administered Orally Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccines Administered Orally Market Size Markets, 2022 & 2030
4.1.2 Human
4.1.3 Animal
4.2 By Type - Global Vaccines Administered Orally Revenue & Forecasts
4.2.1 By Type - Global Vaccines Administered Orally Revenue, 2018-2023
4.2.2 By Type - Global Vaccines Administered Orally Revenue, 2024-2030
4.2.3 By Type - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
4.3 By Type - Global Vaccines Administered Orally Sales & Forecasts
4.3.1 By Type - Global Vaccines Administered Orally Sales, 2018-2023
4.3.2 By Type - Global Vaccines Administered Orally Sales, 2024-2030
4.3.3 By Type - Global Vaccines Administered Orally Sales Market Share, 2018-2030
4.4 By Type - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccines Administered Orally Market Size, 2022 & 2030
5.1.2 Public
5.1.3 Private
5.2 By Application - Global Vaccines Administered Orally Revenue & Forecasts
5.2.1 By Application - Global Vaccines Administered Orally Revenue, 2018-2023
5.2.2 By Application - Global Vaccines Administered Orally Revenue, 2024-2030
5.2.3 By Application - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
5.3 By Application - Global Vaccines Administered Orally Sales & Forecasts
5.3.1 By Application - Global Vaccines Administered Orally Sales, 2018-2023
5.3.2 By Application - Global Vaccines Administered Orally Sales, 2024-2030
5.3.3 By Application - Global Vaccines Administered Orally Sales Market Share, 2018-2030
5.4 By Application - Global Vaccines Administered Orally Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Vaccines Administered Orally Market Size, 2022 & 2030
6.2 By Region - Global Vaccines Administered Orally Revenue & Forecasts
6.2.1 By Region - Global Vaccines Administered Orally Revenue, 2018-2023
6.2.2 By Region - Global Vaccines Administered Orally Revenue, 2024-2030
6.2.3 By Region - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
6.3 By Region - Global Vaccines Administered Orally Sales & Forecasts
6.3.1 By Region - Global Vaccines Administered Orally Sales, 2018-2023
6.3.2 By Region - Global Vaccines Administered Orally Sales, 2024-2030
6.3.3 By Region - Global Vaccines Administered Orally Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Vaccines Administered Orally Revenue, 2018-2030
6.4.2 By Country - North America Vaccines Administered Orally Sales, 2018-2030
6.4.3 US Vaccines Administered Orally Market Size, 2018-2030
6.4.4 Canada Vaccines Administered Orally Market Size, 2018-2030
6.4.5 Mexico Vaccines Administered Orally Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Vaccines Administered Orally Revenue, 2018-2030
6.5.2 By Country - Europe Vaccines Administered Orally Sales, 2018-2030
6.5.3 Germany Vaccines Administered Orally Market Size, 2018-2030
6.5.4 France Vaccines Administered Orally Market Size, 2018-2030
6.5.5 U.K. Vaccines Administered Orally Market Size, 2018-2030
6.5.6 Italy Vaccines Administered Orally Market Size, 2018-2030
6.5.7 Russia Vaccines Administered Orally Market Size, 2018-2030
6.5.8 Nordic Countries Vaccines Administered Orally Market Size, 2018-2030
6.5.9 Benelux Vaccines Administered Orally Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Vaccines Administered Orally Revenue, 2018-2030
6.6.2 By Region - Asia Vaccines Administered Orally Sales, 2018-2030
6.6.3 China Vaccines Administered Orally Market Size, 2018-2030
6.6.4 Japan Vaccines Administered Orally Market Size, 2018-2030
6.6.5 South Korea Vaccines Administered Orally Market Size, 2018-2030
6.6.6 Southeast Asia Vaccines Administered Orally Market Size, 2018-2030
6.6.7 India Vaccines Administered Orally Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Vaccines Administered Orally Revenue, 2018-2030
6.7.2 By Country - South America Vaccines Administered Orally Sales, 2018-2030
6.7.3 Brazil Vaccines Administered Orally Market Size, 2018-2030
6.7.4 Argentina Vaccines Administered Orally Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccines Administered Orally Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Vaccines Administered Orally Sales, 2018-2030
6.8.3 Turkey Vaccines Administered Orally Market Size, 2018-2030
6.8.4 Israel Vaccines Administered Orally Market Size, 2018-2030
6.8.5 Saudi Arabia Vaccines Administered Orally Market Size, 2018-2030
6.8.6 UAE Vaccines Administered Orally Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Vaccines Administered Orally Major Product Offerings
7.1.4 Merck Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Vaccines Administered Orally Major Product Offerings
7.2.4 GSK Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Vaccines Administered Orally Major Product Offerings
7.3.4 Sanofi Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Company Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Vaccines Administered Orally Major Product Offerings
7.4.4 Lanzhou Institute Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.4.5 Lanzhou Institute Key News & Latest Developments
7.5 Serum Institute
7.5.1 Serum Institute Company Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Vaccines Administered Orally Major Product Offerings
7.5.4 Serum Institute Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute Key News & Latest Developments
7.6 Valneva
7.6.1 Valneva Company Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Vaccines Administered Orally Major Product Offerings
7.6.4 Valneva Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.6.5 Valneva Key News & Latest Developments
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Company Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Vaccines Administered Orally Major Product Offerings
7.7.4 Shanghai United Cell Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.7.5 Shanghai United Cell Key News & Latest Developments
7.8 Bibcol
7.8.1 Bibcol Company Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Vaccines Administered Orally Major Product Offerings
7.8.4 Bibcol Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.8.5 Bibcol Key News & Latest Developments
7.9 PaxVax
7.9.1 PaxVax Company Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Vaccines Administered Orally Major Product Offerings
7.9.4 PaxVax Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.9.5 PaxVax Key News & Latest Developments
7.10 Vabiotech
7.10.1 Vabiotech Company Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Vaccines Administered Orally Major Product Offerings
7.10.4 Vabiotech Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.10.5 Vabiotech Key News & Latest Developments
7.11 Tiantan Biological
7.11.1 Tiantan Biological Company Summary
7.11.2 Tiantan Biological Vaccines Administered Orally Business Overview
7.11.3 Tiantan Biological Vaccines Administered Orally Major Product Offerings
7.11.4 Tiantan Biological Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.11.5 Tiantan Biological Key News & Latest Developments
7.12 EuBiologics
7.12.1 EuBiologics Company Summary
7.12.2 EuBiologics Vaccines Administered Orally Business Overview
7.12.3 EuBiologics Vaccines Administered Orally Major Product Offerings
7.12.4 EuBiologics Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.12.5 EuBiologics Key News & Latest Developments
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Company Summary
7.13.2 Panacea Biotec Ltd Vaccines Administered Orally Business Overview
7.13.3 Panacea Biotec Ltd Vaccines Administered Orally Major Product Offerings
7.13.4 Panacea Biotec Ltd Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.13.5 Panacea Biotec Ltd Key News & Latest Developments
7.14 Bio-Med
7.14.1 Bio-Med Company Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Vaccines Administered Orally Major Product Offerings
7.14.4 Bio-Med Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.14.5 Bio-Med Key News & Latest Developments
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Company Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales and Revenue in Global (2018-2023)
7.15.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Vaccines Administered Orally Production Capacity, Analysis
8.1 Global Vaccines Administered Orally Production Capacity, 2018-2030
8.2 Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccines Administered Orally Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccines Administered Orally Supply Chain Analysis
10.1 Vaccines Administered Orally Industry Value Chain
10.2 Vaccines Administered Orally Upstream Market
10.3 Vaccines Administered Orally Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccines Administered Orally Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Vaccines Administered Orally in Global Market
Table 2. Top Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Vaccines Administered Orally Revenue Share by Companies, 2018-2023
Table 5. Global Vaccines Administered Orally Sales by Companies, (K Units), 2018-2023
Table 6. Global Vaccines Administered Orally Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vaccines Administered Orally Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Vaccines Administered Orally Product Type
Table 9. List of Global Tier 1 Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Vaccines Administered Orally Sales (K Units), 2018-2023
Table 15. By Type - Global Vaccines Administered Orally Sales (K Units), 2024-2030
Table 16. By Application ? Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Vaccines Administered Orally Sales (K Units), 2018-2023
Table 20. By Application - Global Vaccines Administered Orally Sales (K Units), 2024-2030
Table 21. By Region ? Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Vaccines Administered Orally Sales (K Units), 2018-2023
Table 25. By Region - Global Vaccines Administered Orally Sales (K Units), 2024-2030
Table 26. By Country - North America Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 29. By Country - North America Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 30. By Country - Europe Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 33. By Country - Europe Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 34. By Region - Asia Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 37. By Region - Asia Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 38. By Country - South America Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 41. By Country - South America Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 46. Merck Company Summary
Table 47. Merck Vaccines Administered Orally Product Offerings
Table 48. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Vaccines Administered Orally Product Offerings
Table 52. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Vaccines Administered Orally Product Offerings
Table 56. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Lanzhou Institute Company Summary
Table 59. Lanzhou Institute Vaccines Administered Orally Product Offerings
Table 60. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Lanzhou Institute Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute Vaccines Administered Orally Product Offerings
Table 64. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Serum Institute Key News & Latest Developments
Table 66. Valneva Company Summary
Table 67. Valneva Vaccines Administered Orally Product Offerings
Table 68. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Valneva Key News & Latest Developments
Table 70. Shanghai United Cell Company Summary
Table 71. Shanghai United Cell Vaccines Administered Orally Product Offerings
Table 72. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shanghai United Cell Key News & Latest Developments
Table 74. Bibcol Company Summary
Table 75. Bibcol Vaccines Administered Orally Product Offerings
Table 76. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bibcol Key News & Latest Developments
Table 78. PaxVax Company Summary
Table 79. PaxVax Vaccines Administered Orally Product Offerings
Table 80. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. PaxVax Key News & Latest Developments
Table 82. Vabiotech Company Summary
Table 83. Vabiotech Vaccines Administered Orally Product Offerings
Table 84. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Vabiotech Key News & Latest Developments
Table 86. Tiantan Biological Company Summary
Table 87. Tiantan Biological Vaccines Administered Orally Product Offerings
Table 88. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tiantan Biological Key News & Latest Developments
Table 90. EuBiologics Company Summary
Table 91. EuBiologics Vaccines Administered Orally Product Offerings
Table 92. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. EuBiologics Key News & Latest Developments
Table 94. Panacea Biotec Ltd Company Summary
Table 95. Panacea Biotec Ltd Vaccines Administered Orally Product Offerings
Table 96. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Panacea Biotec Ltd Key News & Latest Developments
Table 98. Bio-Med Company Summary
Table 99. Bio-Med Vaccines Administered Orally Product Offerings
Table 100. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Bio-Med Key News & Latest Developments
Table 102. Halfkin Bio-Pharmaceuticals Company Summary
Table 103. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offerings
Table 104. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 106. Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Vaccines Administered Orally Production by Region, 2018-2023 (K Units)
Table 109. Global Vaccines Administered Orally Production by Region, 2024-2030 (K Units)
Table 110. Vaccines Administered Orally Market Opportunities & Trends in Global Market
Table 111. Vaccines Administered Orally Market Drivers in Global Market
Table 112. Vaccines Administered Orally Market Restraints in Global Market
Table 113. Vaccines Administered Orally Raw Materials
Table 114. Vaccines Administered Orally Raw Materials Suppliers in Global Market
Table 115. Typical Vaccines Administered Orally Downstream
Table 116. Vaccines Administered Orally Downstream Clients in Global Market
Table 117. Vaccines Administered Orally Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vaccines Administered Orally Segment by Type in 2022
Figure 2. Vaccines Administered Orally Segment by Application in 2022
Figure 3. Global Vaccines Administered Orally Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vaccines Administered Orally Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Vaccines Administered Orally Revenue, 2018-2030 (US$, Mn)
Figure 7. Vaccines Administered Orally Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vaccines Administered Orally Revenue in 2022
Figure 9. By Type - Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 11. By Type - Global Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 12. By Type - Global Vaccines Administered Orally Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 15. By Application - Global Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 16. By Application - Global Vaccines Administered Orally Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Vaccines Administered Orally Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 20. By Region - Global Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 21. By Country - North America Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 22. By Country - North America Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 23. US Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 28. Germany Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 29. France Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 37. China Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 41. India Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 43. By Country - South America Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 44. Brazil Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 48. Turkey Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 52. Global Vaccines Administered Orally Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Vaccines Administered Orally by Region, 2022 VS 2030
Figure 54. Vaccines Administered Orally Industry Value Chain
Figure 55. Marketing Channels
